Beta Drugs Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Beta Drugs has a total shareholder equity of ₹1.6B and total debt of ₹147.1M, which brings its debt-to-equity ratio to 9.4%. Its total assets and total liabilities are ₹2.5B and ₹969.8M respectively. Beta Drugs's EBIT is ₹501.3M making its interest coverage ratio 31.5. It has cash and short-term investments of ₹286.3M.
Belangrijke informatie
9.4%
Verhouding schuld/eigen vermogen
₹147.11m
Schuld
| Rente dekkingsratio | 31.5x |
| Contant | ₹286.33m |
| Aandelen | ₹1.57b |
| Totaal verplichtingen | ₹969.82m |
| Totaal activa | ₹2.54b |
Recente financiële gezondheidsupdates
These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Jul 29
Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
Dec 20These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Sep 02Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
May 20Is Beta Drugs (NSE:BETA) A Risky Investment?
Jan 29Recent updates
Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?
Aug 30Investors Appear Satisfied With Beta Drugs Limited's (NSE:BETA) Prospects As Shares Rocket 27%
Aug 30Earnings Tell The Story For Beta Drugs Limited (NSE:BETA) As Its Stock Soars 29%
Dec 23Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?
Dec 11These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Jul 29Here's Why We Think Beta Drugs (NSE:BETA) Is Well Worth Watching
Jun 17Here's Why I Think Beta Drugs (NSE:BETA) Might Deserve Your Attention Today
Feb 21Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
Dec 20With EPS Growth And More, Beta Drugs (NSE:BETA) Is Interesting
Nov 21These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Sep 02Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
May 20Is Beta Drugs (NSE:BETA) A Risky Investment?
Jan 29Is Beta Drugs Limited's (NSE:BETA) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Dec 25Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)
Nov 20
Analyse van de financiële positie
Kortlopende schulden: BETA's short term assets (₹1.8B) exceed its short term liabilities (₹846.7M).
Langlopende schulden: BETA's short term assets (₹1.8B) exceed its long term liabilities (₹123.1M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: BETA has more cash than its total debt.
Schuld verminderen: BETA's debt to equity ratio has reduced from 49.8% to 9.4% over the past 5 years.
Schuldendekking: BETA's debt is well covered by operating cash flow (210.3%).
Rentedekking: BETA's interest payments on its debt are well covered by EBIT (31.5x coverage).